Cancer Genomics

A blend of a few genomic modifications cooperates to advance cancer. The field of malignancy genomics is a moderately new research range that exploits late innovative advances to concentrate the human genome. The application of metabolomics towards malignancy has prompted a recharged valuation for digestion in growth advancement and movement. It has likewise prompted the disclosure of metabolite malignancy biomarkers.

  • Human genome
  • Genomic modifications
  • Innovative advances in cancer
  • Cancer Pharmacogenomics

Related Conference of Cancer Genomics

October 18-20, 2017

25th World Congress on Cancer Science and Therapy

Baltimore, Maryland, USA
Oct 19-21, 2017

25th World Cancer Conference

Rome, Italy
October 26-28, 2017

9th International Conference on Biomarkers

Osaka,Japan
November 06-08, 2017

2nd International Congress on Epigenetics & Chromatin

Frankfurt, Germany (H4 Hotel Frankfurt Messe)
November 20-22, 2017

14th Asia Pacific
Oncologists Annual Meeting

Melbourne, Australia
November 27-28, 2017

26th World Cancer Convention

Dubai, UAE
November 27- 28, 2017

International Conference on Cancer Diagnostics

Dubai, UAE
December 07-08, 2017

9th World Biomarkers Congress

Madrid, Spain
March 12-14, 2018

Global Summit on Oncology & Cancer

Singapore
April 16-17, 2018

Global Meeting on Oncology and Radiology

Dubai, UAE
May 24-25, 2018

22nd Global Annual Oncologists Meeting

Osaka, Japan
July 18-19, 2018

4th Annual Conference on Preventive oncology

Atlanta, USA
July 18-19, 2018

4th Annual Conference on Gynecologic Oncology

Atlanta, USA
August 09-10, 2018

28th Euro Congress on Cancer Science & Therapy

Madrid, Spain
September 20-21, 2018

3rd Oncologist & Diagnostics Conference 2018

Germany, Berlin
October 26-27, 2018

International Conference on Robotic Oncology

Osaka, Japan
July 11-12, 2018

Experts Meet On Cancer Therapy 2018

Sydney, Australia

Cancer Genomics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in